SciSparc Secures Strategic Advantage with Grant of European Patent
May 31, 2024 07:17 ET
|
SciSparc Ltd
TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...